The effect of ingestion of fucoidan derived from Cladosiphon okamuranus Tokida on human NK cells: A randomized, double-blind, placebo-controlled trial. - The effect of ingestion of fucoidan derived from Cladosiphon okamuranus Tokida on human NK cells: A randomized, double-blind, placebo-controlled trial.

KSO Corporation0 个研究点目标入组 40 人开始时间: 2021年4月3日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Persons who have a serious disease, are undergoing treatment, have a medical history 2)Persons who have a chronic disease and regularly use drugs 3)Persons who regularly use supplements/health foods (including foods for specified health use and foods with functional claims) that may affect immunity 4)Persons who constantly drink more than proper drinking (500 mL per bottle of beer on average per day) 5)Persons who cannot stop drinking from 2 days before each test 6)Persons who have been declared to have allergies 7)Persons with a history of gastrointestinal diseases and gastrointestinal surgery 8)Persons who participants in trials using other foods, medicines and cosmetics 9)Persons who are pregnant, willing to become pregnant during the test period, or breastfeeding 10)Person who the doctor responsible for the study deems inappropriate as a subject

发起方